Recombinant NKG2A (Monalizumab Biosimilar) antibody

Catalog No. ABIN7490930

The Humanized Monoclonal anti-NKG2A (Monalizumab Biosimilar) antibody has been validated for FACS. It is suitable to detect NKG2A (Monalizumab Biosimilar) in samples from Human.

Quick Overview for Recombinant NKG2A (Monalizumab Biosimilar) antibody (ABIN7490930)

Target: NKG2A (Monalizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This NKG2A (Monalizumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS)

Grade: Research Grade

Product Details anti-NKG2A (Monalizumab Biosimilar) Antibody

Purpose: Anti-NKG2A (monalizumab biosimilar) mAb

Characteristics: IPH-2201, IPH2201, NN-8765, NNC-0141-0000-0100, NNC-141-01000, anti-NKG2A, humZ270

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG4

Application Details

Application Notes: Flow Cyt 1:100

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for NKG2A (Monalizumab Biosimilar)

Target: NKG2A (Monalizumab Biosimilar)

Target Type: Biosimilar

Background: Synonyms: CD159A, NKG2, NKG2A

UniProt: P26715